Arterial Venous Blood Tubing Sets for Hemodialysis
Baxter Healthcare
FDA Clearance Information
The arterial venous blood tubing sets by Baxter Healthcare were cleared by the FDA through the 510(k) pathway on December 17, 1993. They are classified as Class 2 devices under product code FJK.
What It Is
FDA-Cleared Indications
- Use as blood tubing in hemodialysis.
- Connect the patient’s vascular access to the hemodialysis system for removal and return of blood.
- Use with compatible hemodialysis equipment according to the manufacturer’s labeling.
Clinical Applications
- Connecting an arteriovenous fistula, graft, or dialysis catheter to the hemodialysis circuit.
- Transporting blood from the patient to the dialyzer during hemodialysis.
- Returning dialyzed blood from the extracorporeal circuit to the patient.
- Use during intermittent hemodialysis in hospital or outpatient dialysis settings, when compatible with the dialysis machine and treatment protocol.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The set must be compatible with the hemodialysis machine, dialyzer, vascular access, connectors, and prescribed blood-flow rate.
- Tubing sets are typically sterile, single-use products and should be inspected for damage, leaks, contamination, or expired packaging before use.
- Correct identification of the arterial and venous lines is important to maintain the intended blood-flow direction and reduce the risk of circuit errors.
- Air detection, pressure monitoring, anticoagulation, priming, and connection procedures must follow the dialysis unit’s protocol and the device labeling.
- These tubing sets are not implants and are not independently evaluated as MRI-safe devices; MRI compatibility depends on the complete dialysis setup and whether the equipment can be safely removed from the MRI environment.
Frequently Asked Questions
What are the clinical indications for arterial venous blood tubing sets?
These tubing sets are indicated for use in hemodialysis to facilitate blood flow between the patient and the dialysis machine.
What outcomes have been reported in clinical studies?
Studies report effective hemodynamic stability and reduced infection rates with proper use and timely replacement of the tubing sets.
What complications have been reported?
Safety data indicate potential for increased infection rates and hemodynamic instability if not used according to clinical guidelines.